T he Cancer Survivor's Bill of Rights (American Cancer Society, 1988) states that health care professionals should be "informative and open, providing survivors with as much or as little candid medical [health] information as they wish, and encouraging their informed participation in their own care." To be "informative" one must be knowledgeable of the state of the art of that particular field, yet even the specialist finds a rapidly changing field such as oncology incomprehensible. How, then, can the occupational health nurse, who is, of necessity, a generalist, fulfill this obligation to "be informed" with respect to all of the major health problems?
AAOHN has addressed this problem, in part, by dedicating entire issues of the AAOHN Journal to health problems of high priority. As an oncology nurse educator, I applaud the choice of breast cancer as the topic for this issue.
In 1988, breast cancer was surpassed by lung cancer as the leading cause of cancer deaths in women. In this case, jockeying to be number one is a dubious distinction, and American women are the losers whichever WInS.
One distinction between the occurrence of the two types of malignancies is that the primary cause of lung cancer is known (ie, smoking) and lifestyle choices can be made accordingly. However, with predictions that one in ten American women will have breast cancer, much less is known about how the individual can alter life styles and beat the odds of becoming "the one."
Likewise, once the diagnosis is made, controversy abounds on the one best treatment. To compound this dilemma, physicians are under legal and ethical mandates to include the client in treatment decisions. If the specialist faces treatment dilemmas, then imagine the burden of decision making for the layperson who has just been diagnosed with breast cancer. Imagine, as well, the potential for guilt and/or regret as that individual lives with these decisions either as a survivor of breast cancer or as one of the 30% who fail to survive.
The intent of this issue is to expand this scenario of the experience of breast cancer in American women and men to enhance the sensitivitv and effectiveness of nurses who have the privilege of "being there" for breast cancer prevention, detection, treatment, and follow-up in the workplace. Terms such as "oncogenes," "monoclonal an tibodies," and "chemoprevention" postdate the educational curricula of the majority of nurses; therefore, the content is selected to update previously acquired knowledge in the field.
Authors selected for this issue are specialists in oncology education, administration, and/or practice. Collectively, these authors have over 100 years of oncology experience which complements the formal education of the respective contributors and culminates in a very responsible recounting of strategies to "encourage informed participation" of the public and professionals in breast cancer prevention, treatment, and rehabilitation.
Rights also infer responsibility. The history of breast cancer management is replete with examples of how responsible actions by clients, professionals, and communities have contributed to the length and quality of the life of persons with breast cancer. Some of these actions have been proactive, such as the development of the Reach to Recovery program by Terese Lasser, a woman with breast cancer.
Other actions have been reactive such as the media blitz on the radiation hazards of mammography. Altogether the breast cancer movement has been a cooperative effort of lay and professional individuals and groups.
Doomsayers lament that no progress has been made in breast cancer management. Others say the progress has been too slow. Still others are exu berant about progress measured in increments; such as the reality of an early detection technique (mammography), application of accrued knowledge of the biology of breast cancer to the development of more definitive yet less radical treatment protocols, and the masterful results achievable with breast reconstruction.
Both clients and professionals have the right to know and the responsibility to act to lessen the morbidity and mortality of breast cancer. If this issue makes the challenge of these rights and responsibilities more explicit, then the objective of the contributors will have been achieved.
